Navigation Links
Study Reveals How Salmonella 'Hijacks' Cells
Date:4/16/2009

Researchers spot mechanism that may be applicable to other pathogens

THURSDAY, April 16 (HealthDay News) -- A protein called SopB enables salmonella bacteria to invade cells that line the intestine and hijack cellular functions to avoid destruction, Yale University researchers report.

Their finding offers new insight into how disease is caused by salmonella, which kills more than 2 million people a year.

"In evolutionary terms, this hijacking of cellular machinery to diversify the function of a bacterial protein is mind-boggling," study senior author Jorge Galan, chair of microbial pathogenesis at Yale, said in a university news release.

The study was published in the April 15 issue of Cell.

"These studies provide a unique insight into the mechanisms by which this important pathogen causes disease. In addition, this finding may point to a novel paradigm that may be applicable to other important pathogens," Galan said.

More information

The U.S. Centers for Disease Control and Prevention has more about salmonella infection.



-- Robert Preidt



SOURCE: Yale University, news release, April 15, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Study Fails to Establish Link Between Cancer and Firefighting
2. Kaiser Permanente Receives Top Marks in 2009 J.D. Power and Associates Study
3. Capgemini Releases New Study on Financial Impact of Masimo Noninvasive and Continuous Hemoglobin (SpHb(TM))
4. Study Shows Consumers With High Deductible Health Plans Are More Savvy About Controlling Costs, Improving Health
5. Medifocus Inc. Reports Improved Clinical Efficacy for its Phase II, Randomized Clinical Study for the Treatment of Early Stage Breast Cancer Tumors
6. UCSF, Stanford Study Reveals Neural Networks Targeted in Brain Diseases
7. Harvard Business School Publishes Case Study on Youth Villages in North Carolina
8. Harvard Business School Publishes Case Study on Youth Villages-Intercept in Texas
9. Study suggests that trouble sleeping leads to increased ratings of pain in cancer patients
10. Study Finds Discontinuation of Rosiglitazone Left Many Diabetes Patients Without Good Glycemic Control
11. Study reports success in treating a rare retinal disorder
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Reveals How Salmonella 'Hijacks' Cells
(Date:4/24/2017)... ... April 24, 2017 , ... Labs often perform the ... for lab operators and management to assess these processes with a critical eye—particularly ... unnecessary actions. , Created with the help of both internal and external ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... clearly shows that over the last decade, student well-being has seriously declined. "When ... boxes of formal education, join the Islamic State to turn the historic multi-ethnic ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Learning to Use Your SPIRITUAL ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues” is the creation ... former Chairman of the Board of Directors for CONTACT USA, and former member of ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... Gallardo, DDS, PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium ... , The Oral Reconstruction Foundation will present its annual Global Symposium at the ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... brands, work wear distributors and International relief organizations across the globe to provide ... also offers lifestyle and work wear collections via insectshield.com . In the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... YORK , April 19, 2017 Cardiology devices ... the projected period The Cardiology Devices segment is ... than US$ 15 Mn in 2018 over 2017. By the ... a market valuation close to US$ 700 Mn, expanding at ... Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology: